⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22731956 | 0.81 | DGAT1 (0.32) | — | |
| SCHEMBL22717311 | 0.80 | DGAT1 (0.34) | — | |
| SCHEMBL30311811 | 0.80 | DGAT1 (0.34) | — | |
| SCHEMBL30365647 | 0.78 | MAPT (0.31) | — | |
| SCHEMBL27200473 | 0.78 | MAPT (0.31) | — | |
| SCHEMBL22732165 | 0.78 | F2RL1 (0.32) | — | |
| SCHEMBL29574531 | 0.78 | F2RL1 (0.32) | — | |
| SCHEMBL22717739 | 0.77 | — | — | |
| SCHEMBL32676004 | 0.77 | — | — | |
| SCHEMBL25176510 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230140983-A1 | PYRIDAZINE DERIVATIVES FOR MODULATING NUCLEIC ACID SPLICING | REMIX THERAPEUTICS INC (US) | 2023-05-11 | — | — | US | disclosed |
| EP-4110774-A1 | PYRIDAZINE DERIVATIVES FOR MODULATING NUCLEIC ACID SPLICING | Remix Therapeutics Inc. (US) | 2023-01-04 | — | — | EP | disclosed |
| WO-2021174176-A9 | PYRIDAZINE DERIVATIVES FOR MODULATING NUCLEIC ACID SPLICING | REMIX THERAPEUTICS INC. (US) | 2022-09-15 | — | — | WO | disclosed |